1174 related articles for article (PubMed ID: 32311498)
21. Lifestyle and severe SARS-CoV-2 infections: Does the individual metabolic burden determines the outcome?
Markus B; Kreutz J; Schieffer B
J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320963929. PubMed ID: 33040679
[No Abstract] [Full Text] [Related]
22. From Influenza Virus to Novel Corona Virus (SARS-CoV-2)-The Contribution of Obesity.
Bhattacharya I; Ghayor C; Pérez Dominguez A; Weber FE
Front Endocrinol (Lausanne); 2020; 11():556962. PubMed ID: 33123087
[TBL] [Abstract][Full Text] [Related]
23. SARS-CoV-2 infection in patients with diabetes mellitus and hypertension: a systematic review.
Deravi N; Fathi M; Vakili K; Yaghoobpoor S; Pirzadeh M; Mokhtari M; Fazel T; Ahsan E; Ghaffari S
Rev Cardiovasc Med; 2020 Sep; 21(3):385-397. PubMed ID: 33070543
[TBL] [Abstract][Full Text] [Related]
24. The COVID-19 pandemic through eyes of a NYC fertility center: a unique learning experience with often unexpected results.
Gleicher N
Reprod Biol Endocrinol; 2020 Nov; 18(1):105. PubMed ID: 33148264
[TBL] [Abstract][Full Text] [Related]
25. Deciphering the Role of Host Genetics in Susceptibility to Severe COVID-19.
Carter-Timofte ME; Jørgensen SE; Freytag MR; Thomsen MM; Brinck Andersen NS; Al-Mousawi A; Hait AS; Mogensen TH
Front Immunol; 2020; 11():1606. PubMed ID: 32695122
[TBL] [Abstract][Full Text] [Related]
26. Putative contributions of circadian clock and sleep in the context of SARS-CoV-2 infection.
Meira E Cruz M; Miyazawa M; Gozal D
Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32350105
[TBL] [Abstract][Full Text] [Related]
27. Long-term and herd immunity against SARS-CoV-2: implications from current and past knowledge.
Papachristodoulou E; Kakoullis L; Parperis K; Panos G
Pathog Dis; 2020 Apr; 78(3):. PubMed ID: 32510562
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms.
Raucci F; Mansour AA; Casillo GM; Saviano A; Caso F; Scarpa R; Mascolo N; Iqbal AJ; Maione F
Autoimmun Rev; 2020 Jul; 19(7):102572. PubMed ID: 32376393
[No Abstract] [Full Text] [Related]
29. Immune status could be associated with severity in COVID-19 patients.
Liu C; Yang J; Wang W; Mi Y; Tang Y; Zheng P
Rev Assoc Med Bras (1992); 2020; 66Suppl 2(Suppl 2):13-16. PubMed ID: 32965348
[No Abstract] [Full Text] [Related]
30. What's Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses.
Gadi N; Wu SC; Spihlman AP; Moulton VR
Front Immunol; 2020; 11():2147. PubMed ID: 32983176
[TBL] [Abstract][Full Text] [Related]
31. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.
Bello-Chavolla OY; Bahena-López JP; Antonio-Villa NE; Vargas-Vázquez A; González-Díaz A; Márquez-Salinas A; Fermín-Martínez CA; Naveja JJ; Aguilar-Salinas CA
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32474598
[TBL] [Abstract][Full Text] [Related]
32. New view on older adults with COVID-19: comments on "SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes".
Xu G; Ye M; Zhao J; Liu F; Ma W
Geroscience; 2020 Oct; 42(5):1225-1227. PubMed ID: 32710258
[No Abstract] [Full Text] [Related]
33. Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes.
Korakas E; Ikonomidis I; Kousathana F; Balampanis K; Kountouri A; Raptis A; Palaiodimou L; Kokkinos A; Lambadiari V
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E105-E109. PubMed ID: 32459524
[TBL] [Abstract][Full Text] [Related]
34. Impact of Diabetes in Patients Diagnosed With COVID-19.
Abu-Farha M; Al-Mulla F; Thanaraj TA; Kavalakatt S; Ali H; Abdul Ghani M; Abubaker J
Front Immunol; 2020; 11():576818. PubMed ID: 33335527
[TBL] [Abstract][Full Text] [Related]
35. The Nutritional and Health Effects of the COVID-19 Pandemic on Patients with Diabetes Mellitus.
Grabia M; Markiewicz-Żukowska R; Puścion-Jakubik A; Bielecka J; Nowakowski P; Gromkowska-Kępka K; Mielcarek K; Socha K
Nutrients; 2020 Sep; 12(10):. PubMed ID: 33008059
[TBL] [Abstract][Full Text] [Related]
36. COVID-19-a very visible pandemic.
Durrheim DN; Baker MG
Lancet; 2020 Aug; 396(10248):e17. PubMed ID: 32771112
[No Abstract] [Full Text] [Related]
37. Herd immunity - estimating the level required to halt the COVID-19 epidemics in affected countries.
Kwok KO; Lai F; Wei WI; Wong SYS; Tang JWT
J Infect; 2020 Jun; 80(6):e32-e33. PubMed ID: 32209383
[No Abstract] [Full Text] [Related]
38. SARS-CoV-2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors.
Stilhano RS; Costa AJ; Nishino MS; Shams S; Bartolomeo CS; Breithaupt-Faloppa AC; Silva EA; Ramirez AL; Prado CM; Ureshino RP
FASEB J; 2020 Nov; 34(11):14103-14119. PubMed ID: 32965736
[TBL] [Abstract][Full Text] [Related]
39. Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series.
Vetter P; Eberhardt CS; Meyer B; Martinez Murillo PA; Torriani G; Pigny F; Lemeille S; Cordey S; Laubscher F; Vu DL; Calame A; Schibler M; Jacquerioz F; Blanchard-Rohner G; Siegrist CA; Kaiser L; Didierlaurent AM; Eckerle I
mSphere; 2020 Nov; 5(6):. PubMed ID: 33177214
[TBL] [Abstract][Full Text] [Related]
40. Strengthening the Immune System and Reducing Inflammation and Oxidative Stress through Diet and Nutrition: Considerations during the COVID-19 Crisis.
Iddir M; Brito A; Dingeo G; Fernandez Del Campo SS; Samouda H; La Frano MR; Bohn T
Nutrients; 2020 May; 12(6):. PubMed ID: 32471251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
